Healthcare-focused venture capital firm HealthQuad has secured ₹550 crore in commitments for its third investment fund and is targeting a total corpus of ₹1,700 crore to back early-growth healthcare startups across India. The fund also includes a greenshoe option that could increase the total corpus to ₹2,500 crore.
The latest fund reflects growing investor confidence in India’s healthcare innovation ecosystem, particularly in sectors such as healthtech, medtech, biopharma technology, and emerging healthcare delivery models. HealthQuad expects to achieve the final close of the fund by the middle of next year.
The commitments have come from a mix of existing domestic and global investors from previous funds as well as new limited partners joining the platform.
Fund III to Focus on Next-Generation Healthcare Startups
According to HealthQuad, the new fund will primarily target early-growth companies building technology-led healthcare solutions. Key investment areas include digital health platforms, medical technologies, diagnostics, biopharma innovation, and novel healthcare delivery models.
The firm has already made its first investment from Fund III in Lifesigns, an AI-powered remote patient monitoring platform, signaling its continued interest in technology-driven healthcare businesses.
As healthcare systems increasingly adopt artificial intelligence, remote monitoring, and digital infrastructure, venture capital firms are expanding their focus on startups capable of improving healthcare accessibility, affordability, and efficiency.
The fund positions HealthQuad to capitalize on India’s rapidly evolving healthcare technology landscape.
Building on a Decade of Healthcare Investing
HealthQuad was established as the early-growth investment platform of healthcare-focused private equity firm Quadria Capital. Since its launch, the venture capital platform has backed more than 18 healthcare startups across various segments.
Its portfolio includes companies such as Qure.ai, Wysa, Redcliffe Labs, Cureskin, Strand Life Sciences, Ekincare, THB, GoApptiv, and Medikabazaar, among others. These startups operate across diagnostics, AI-powered healthcare, preventive care, healthcare software, and digital health services.
The platform recently underwent a restructuring following the separation of healthcare investment firms Kois and Quadria within HealthQuad’s ownership structure. However, the investment team managing earlier funds has largely remained intact.
Investor Interest in Healthcare Innovation Remains Strong
The fundraise comes amid increasing investor interest in healthcare and life sciences startups. Rising healthcare spending, growing digital adoption, and advances in AI-powered medical technologies have created significant opportunities for venture-backed companies.
Industry experts believe sectors such as remote patient monitoring, digital therapeutics, diagnostics, and healthcare infrastructure could attract substantial capital over the coming years.
With Fund III, HealthQuad is positioning itself as one of India’s largest specialized healthcare venture investors, aiming to support the next generation of startups transforming how healthcare is delivered and accessed across the country.